Programme Category
Programme Name
Identifier Code
Call
Summary
The European Partnership for Personalised Medicine, EP PerMed, is a platform for joint programming of national and European regional research and innovation (R&I) programmes putting into action “The Strategic Research & Innovation Agenda (SRIA) for Personalised Medicine (2023)” SRIA for PM (2023), through dedicated research, development and innovation funding.
Detailed Call Description
The Fast Track Validation Programme aims to accelerate the development and adoption of at least 5 innovative PM solutions in 2025, fostering advancements that can transform healthcare and improve patient outcomes.
The programme contributes to the overarching goal of Personalised Medicine: delivering tailored, effective, and efficient healthcare solutions that meet the unique needs of each patient.
Upon programme completion, participants will have rigorously tested and refined their innovations in realistic settings, elevating their projects by at least one TRL. This process ensures that solutions move to a higher level of technological and market readiness.
Call Total Budget
Financing percentage by EU or other bodies / Level of Subsidy or Loan
The total available budget under the present call is €400.000. Selected projects will receive funding of up to €80.000 per project, which can be used to cover validation services and other eligible costs.
At least 70% of the budget should be allocated to user validation services. The funding will be provided through lump sum contracts, with 50% pre-payment and the remaining 50% disbursed upon approval of the final activity report.
Thematic Categories
- Education and training
- Health
- New Entrepreneurship
- Research, Technological Development and Innovation
Eligibility for Participation
- Educational Institutions
- Other Beneficiaries
- Researchers/Research Centers/Institutions
Eligibility For Participation Notes
The EP PerMed Fast Track Validation Programme is open to start-ups, or small teams and researchers who are looking to advance their PM innovations through rigorous validation studies. The programme targets solutions that are at least at the proof-of-concept stage (TRL3).
The application can be submitted with or without an already selected validation centre. When applying without a validation centre, the application must present a clear view on what kind of validation partner is needed for the project. This will help facilitate matching the application with an appropriate validation centre.
Applications can be submitted by either a start-up or a team/researcher affiliated with an academic or healthcare research organisation registered in an EU Member State or a Horizon Europe-associated country.
For incorporated start-ups, make sure to register in the EIT Health Application Platform as a representative of a start-up or independent team. For Teams or Researchers affiliated with an academic or healthcare research organisation, please register as a representative of an organization (excluding start-ups).
Call Opening Date
Call Closing Date
EU Contact Point
For further details please contact:
Name: Mohammed Ilyass Rahmouni
Email: calls_eppermed@eithealth.eu